Related Experiment Video
Updated: May 7, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like receptors and liver disease
1Department of Medicine, Recanati/Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Lenox Hill Hospital, New York, NY, USA.
Abstract:
Toll-like receptors (TLRs) are pattern recognition receptors that play an important role in host defence by recognizing pathogen-associated molecular patterns (PAMP). Recent studies indicate that TLR signalling plays an important role in progression of chronic liver diseases. Ongoing clinical trials suggest that therapeutic manipulation of TLR pathways may offer novel means of reversing chronic liver diseases. Upon activation by their respective ligands, TLRs initiate an intracellular pro-inflammatory/anti-inflammatory signalling cascade via recruitment of various adaptor proteins. TLR associated signalling pathways are tightly regulated to keep a check on inappropriate production of pro-inflammatory cytokines and interferons thereby preventing various autoimmune and inflammatory processes. Herein, we review the current state of knowledge of hepatic distribution, signalling pathways and therapeutic modulation of TLRs in chronic liver diseases.
Insights
Toll-like receptors (TLRs) are key in host defense and chronic liver disease progression. Modulating TLR pathways shows promise for reversing liver diseases by controlling inflammatory signaling.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are pattern recognition receptors crucial for innate immunity.
- TLR signaling is implicated in the pathogenesis of chronic liver diseases.
- Current research explores TLRs as therapeutic targets for liver conditions.
Purpose of the Study:
- To review the hepatic distribution of Toll-like receptors.
- To elucidate TLR signaling pathways in the context of chronic liver diseases.
- To discuss the therapeutic modulation of TLRs for treating liver diseases.
Main Methods:
- Literature review of studies on TLRs in chronic liver diseases.
- Analysis of TLR signaling cascades and their hepatic roles.
- Examination of ongoing and potential therapeutic strategies targeting TLRs.
Main Results:
- TLRs are present in the liver and play a dual role in disease progression.
- TLR activation triggers intracellular signaling pathways influencing inflammation.
- Tight regulation of TLR pathways is essential to prevent excessive inflammation.
Conclusions:
- Understanding TLR distribution and signaling in the liver is critical.
- Therapeutic targeting of TLRs presents a promising avenue for treating chronic liver diseases.
- Further research into TLR modulation could lead to novel regenerative therapies for liver conditions.
More Related Videos
Related Concept Videos
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

